Literature DB >> 18048812

Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials?

Deborah Watkins Bruner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18048812     DOI： 10.1200/JCO.2007.13.3330

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

Review 1.  Role of radiation therapy in palliative care of the patient with cancer.

Authors:  Stephen T Lutz; Joshua Jones; Edward Chow
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

2.  Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.

Authors:  Chantal Quinten; John Maringwa; Carolyn C Gotay; Francesca Martinelli; Corneel Coens; Bryce B Reeve; Henning Flechtner; Eva Greimel; Madeleine King; David Osoba; Charles Cleeland; Jolie Ringash; Joseph Schmucker-Von Koch; Martin J B Taphoorn; Joachim Weis; Andrew Bottomley
Journal:  J Natl Cancer Inst       Date:  2011-12-07       Impact factor: 13.506

3.  Concordance between patient reports of cancer-related symptoms and medical records documentation.

Authors:  Alla Sikorskii; Gwen Wyatt; Deimante Tamkus; David Victorson; Mohammad Hossein Rahbar; Suzie Ahn
Journal:  J Pain Symptom Manage       Date:  2012-06-13       Impact factor: 3.612

Review 4.  Improving modern cancer care through information technology.

Authors:  Steven B Clauser; Edward H Wagner; Erin J Aiello Bowles; Leah Tuzzio; Sarah M Greene
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

5.  Validation of QuickDASH outcome measure in breast cancer survivors for upper extremity disability.

Authors:  Mously LeBlanc; Margaret Stineman; Angela DeMichele; Carrie Stricker; Jun J Mao
Journal:  Arch Phys Med Rehabil       Date:  2013-10-02       Impact factor: 3.966

6.  Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.

Authors:  Ethan Basch; Xiaoyu Jia; Glenn Heller; Allison Barz; Laura Sit; Michael Fruscione; Mark Appawu; Alexia Iasonos; Thomas Atkinson; Shari Goldfarb; Ann Culkin; Mark G Kris; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2009-11-17       Impact factor: 13.506

7.  Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits.

Authors:  L J Fallowfield; S L Catt; S F May; L Matthews; V M Shilling; R Simcock; S Westwell; V A Jenkins
Journal:  Support Care Cancer       Date:  2016-09-13       Impact factor: 3.603

8.  Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy.

Authors:  Timothy J Judson; Antonia V Bennett; Lauren J Rogak; Laura Sit; Allison Barz; Mark G Kris; Clifford A Hudis; Howard I Scher; Paul Sabattini; Deborah Schrag; Ethan Basch
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544

9.  Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma.

Authors:  David Cella; Mellar P Davis; Sylvie Négrier; Robert A Figlin; M Dror Michaelson; Andrew G Bushmakin; Joseph C Cappelleri; Rickard Sandin; Beata Korytowsky; Claudie Charbonneau; Ewa Matczak; Robert J Motzer
Journal:  Cancer       Date:  2014-03-13       Impact factor: 6.860

10.  Bereaved relatives' experiences during the incurable phase of cancer: a qualitative interview study.

Authors:  Marleen N Wijnhoven; Wim E Terpstra; Ronald van Rossem; Carolien Haazer; Nicolette Gunnink-Boonstra; Gabe S Sonke; Hilde M Buiting
Journal:  BMJ Open       Date:  2015-11-25       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.